Appleton Partners Inc Catalent, Inc. Transaction History

Appleton Partners Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$45.44 - $74.26 $259,235 - $423,653	5,705 Added 39.63%	20,102 $1.32 Million
Q4 2022 Jan 19, 2023	BUY	$41.39 - $81.0 $184,019 - $360,126	4,446 Added 44.68%	14,397 $648,000
Q3 2022 Oct 27, 2022	SELL	$72.36 - $113.1 $3,111 - $4,863	-43 Reduced 0.43%	9,951 $720,000
Q2 2022 Jul 08, 2022	BUY	$87.2 - $114.05 $48,396 - $63,297	555 Added 5.88%	9,994 $1.07 Million
Q1 2022 Apr 05, 2022	BUY	$94.19 - $124.49 $32,495 - $42,949	345 Added 3.79%	9,439 $1.05 Million
Q4 2021 Feb 03, 2022	BUY	$119.57 - $139.07 $398,765 - $463,798	3,335 Added 57.91%	9,094 $1.16 Million
Q3 2021 Oct 14, 2021	BUY	$109.17 - $142.35 $278,820 - $363,561	2,554 Added 79.69%	5,759 $766,000
Q2 2021 Jul 07, 2021	BUY	$100.34 - $115.69 $321,589 - $370,786	3,205 New	3,205 $347,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Appleton Partners Inc with notifications on news.